Using fecal immunochemical test values below conventional cut-off to individualize colorectal cancer screening

Background and study aims Of the participants in the Danish screening program, 89.9 % to 92.5 % have fecal immunochemical test (FIT) values < 10 μg/g feces (equivalent to 50 ng hemoglobin/mL buffer). This study aimed to investigate the risk of interval colorectal cancer (CRC) in this group before...

Full description

Bibliographic Details
Main Authors: Eva Plantener, Ulrik Deding, Jeppe Buur Madsen, Rasmus Kroijer, Jonna Skov Madsen, Gunnar Baatrup
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2022-04-01
Series:Endoscopy International Open
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/a-1743-2651
_version_ 1818250838968107008
author Eva Plantener
Ulrik Deding
Jeppe Buur Madsen
Rasmus Kroijer
Jonna Skov Madsen
Gunnar Baatrup
author_facet Eva Plantener
Ulrik Deding
Jeppe Buur Madsen
Rasmus Kroijer
Jonna Skov Madsen
Gunnar Baatrup
author_sort Eva Plantener
collection DOAJ
description Background and study aims Of the participants in the Danish screening program, 89.9 % to 92.5 % have fecal immunochemical test (FIT) values < 10 μg/g feces (equivalent to 50 ng hemoglobin/mL buffer). This study aimed to investigate the risk of interval colorectal cancer (CRC) in this group before the next biennial screening round. Patients and methods This cohort study included all citizens from the region of Southern Denmark who participated in the Danish bowel screening program from 2014 trough 2016 and had a FIT value < 10 μg/g feces. Individuals receiving a CRC diagnosis were identified through the national CRC registry, with a follow up of 2 years corresponding to the current screening interval. We also examined the 3-year CRC incidence. Hazard ratios (HRs) were estimated using univariate and multivariate Cox proportional hazard regression models. Results Data from 185,654 citizens presenting with a FIT value < 10 μg/g feces were eligible for analysis. Overall, interval CRC incidence was 0.07 % within 2 years with HRs of 4.16 (95 % confidence interval [CI] 2.67;6.48) and 5.8 (95 % CI 3.34;10.05) for FIT values of 4 to 6.9 μg/g feces and 7 to 9.9 μg/g feces, respectively, compared to those having a FIT value below the limit of quantification of 4 μg/g feces. After 3 years, the overall CRC incidence increased to 0.14 %; however, this was not significant. Conclusions This study demonstrates a positive correlation between FIT value and risk of interval cancer even for very low values. It further suggests that an increase in the screening interval could be reasonable in the low FIT categories.
first_indexed 2024-12-12T15:58:45Z
format Article
id doaj.art-d7a895417bf745bcb025e5eca0e998e7
institution Directory Open Access Journal
issn 2364-3722
2196-9736
language English
last_indexed 2024-12-12T15:58:45Z
publishDate 2022-04-01
publisher Georg Thieme Verlag KG
record_format Article
series Endoscopy International Open
spelling doaj.art-d7a895417bf745bcb025e5eca0e998e72022-12-22T00:19:26ZengGeorg Thieme Verlag KGEndoscopy International Open2364-37222196-97362022-04-011004E413E41910.1055/a-1743-2651Using fecal immunochemical test values below conventional cut-off to individualize colorectal cancer screeningEva Plantener0Ulrik Deding1Jeppe Buur Madsen2Rasmus Kroijer3Jonna Skov Madsen4Gunnar Baatrup5Odense University Hospital, Department of Surgery, Svendborg, DenmarkOdense University Hospital, Department of Surgery, Svendborg, DenmarkUniversity Hospital Lillebaelt, Department of Biochemistry and Immunology, Vejle, DenmarkHospital South West Jutland, Department of Surgery, Esbjerg, DenmarkUniversity Hospital Lillebaelt, Department of Biochemistry and Immunology, Vejle, DenmarkOdense University Hospital, Department of Surgery, Svendborg, DenmarkBackground and study aims Of the participants in the Danish screening program, 89.9 % to 92.5 % have fecal immunochemical test (FIT) values < 10 μg/g feces (equivalent to 50 ng hemoglobin/mL buffer). This study aimed to investigate the risk of interval colorectal cancer (CRC) in this group before the next biennial screening round. Patients and methods This cohort study included all citizens from the region of Southern Denmark who participated in the Danish bowel screening program from 2014 trough 2016 and had a FIT value < 10 μg/g feces. Individuals receiving a CRC diagnosis were identified through the national CRC registry, with a follow up of 2 years corresponding to the current screening interval. We also examined the 3-year CRC incidence. Hazard ratios (HRs) were estimated using univariate and multivariate Cox proportional hazard regression models. Results Data from 185,654 citizens presenting with a FIT value < 10 μg/g feces were eligible for analysis. Overall, interval CRC incidence was 0.07 % within 2 years with HRs of 4.16 (95 % confidence interval [CI] 2.67;6.48) and 5.8 (95 % CI 3.34;10.05) for FIT values of 4 to 6.9 μg/g feces and 7 to 9.9 μg/g feces, respectively, compared to those having a FIT value below the limit of quantification of 4 μg/g feces. After 3 years, the overall CRC incidence increased to 0.14 %; however, this was not significant. Conclusions This study demonstrates a positive correlation between FIT value and risk of interval cancer even for very low values. It further suggests that an increase in the screening interval could be reasonable in the low FIT categories.http://www.thieme-connect.de/DOI/DOI?10.1055/a-1743-2651
spellingShingle Eva Plantener
Ulrik Deding
Jeppe Buur Madsen
Rasmus Kroijer
Jonna Skov Madsen
Gunnar Baatrup
Using fecal immunochemical test values below conventional cut-off to individualize colorectal cancer screening
Endoscopy International Open
title Using fecal immunochemical test values below conventional cut-off to individualize colorectal cancer screening
title_full Using fecal immunochemical test values below conventional cut-off to individualize colorectal cancer screening
title_fullStr Using fecal immunochemical test values below conventional cut-off to individualize colorectal cancer screening
title_full_unstemmed Using fecal immunochemical test values below conventional cut-off to individualize colorectal cancer screening
title_short Using fecal immunochemical test values below conventional cut-off to individualize colorectal cancer screening
title_sort using fecal immunochemical test values below conventional cut off to individualize colorectal cancer screening
url http://www.thieme-connect.de/DOI/DOI?10.1055/a-1743-2651
work_keys_str_mv AT evaplantener usingfecalimmunochemicaltestvaluesbelowconventionalcutofftoindividualizecolorectalcancerscreening
AT ulrikdeding usingfecalimmunochemicaltestvaluesbelowconventionalcutofftoindividualizecolorectalcancerscreening
AT jeppebuurmadsen usingfecalimmunochemicaltestvaluesbelowconventionalcutofftoindividualizecolorectalcancerscreening
AT rasmuskroijer usingfecalimmunochemicaltestvaluesbelowconventionalcutofftoindividualizecolorectalcancerscreening
AT jonnaskovmadsen usingfecalimmunochemicaltestvaluesbelowconventionalcutofftoindividualizecolorectalcancerscreening
AT gunnarbaatrup usingfecalimmunochemicaltestvaluesbelowconventionalcutofftoindividualizecolorectalcancerscreening